We provide the latest news
from the world of economics and finance
(RTTNews) - Pharmaceutical company Alimera Sciences, Inc. (ALIM) announced Tuesday that Elliot Maltz has been named Chief Financial Officer effective immediately.
Maltz began his career as an audit manager for Deloitte & Touche LLP before joining Sapient Corp. as the Technical Accounting and SEC Reporting Manager. Most recently, he was the CFO with Orgenesis, Inc.
Prior to this, he was with Gelesis Holdings, Inc., where he advanced from Corporate Controller to Vice President of Finance and then to CFO while leading numerous operational and fundraising initiatives.
Maltz will be taking on the role from Russell Skibsted. The company said Skibsted's departure is not the result of any disagreement with management concerning the Company's operations or management.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.